Developing vaccine against pathogenic streptococcus
Published on Monday February 03, 2014
Smooth Drug Development is working on an innovative vaccine for treatment of pathogenic streptococcus.
Smooth Drug Development at social media
Published on Saturday December 28, 2013
Follow Smooth Drug Development in social media: Twitter, LinkedIn, Instagram. Clinical trials can be interesting and exciting.
Smooth assesses results of 2013
Published on Thursday December 26, 2013
Smooth Drug Development assesses its results of 2013. Fast facts: 30+ clinical trials, 50+ employees, 2 phase I units and a new office.
Moving to the new Smooth office
Published on Monday December 02, 2013
Growing team of Smooth Drug Development has moved to the new 300+ square meters office.
Our team attends The Innovative Drug R&D Forum
Published on Wednesday November 13, 2013
Smooth Drug Development team will attend The Innovative Drug R&D Forum 2013 and Clinical Trials Russia Forum.
BioPharma India event
Published on Wednesday November 13, 2013
Smooth Drug Development attends the biopharmaceutical partnering event BioPharma India on November, 25-26.
The new R&D center in St-Petersburg
Published on Tuesday October 22, 2013
Smooth Drug Development announces opening of the new Research and Development center in St-Petersburg.
Performs a new bioequivalence study
Published on Friday September 13, 2013
Smooth Drug Development performs a bioequivalence study of a combination of two antiretroviral drugs.
Smooth Drug Development starts a new bioequivalence trial
Published on Friday September 13, 2013
Smooth Drug Development starts a new bioequivalence study of a non-steroidal anti-inflammatory drug with analgesic and antipyretic action.
Smooth started a phase III clinical trial in tinea versicolor
Published on Wednesday May 08, 2013
Smooth Drug Development started a phase III study in tinea versicolor. It is planned that our team will provide a full-service for this study.
Starts registration of beta and gamma interferons
Published on Monday May 06, 2013
Smooth Drug Development started registration, pre-clinical and clinical research of two biosimilar products: interferon beta-1b and interferon gamma.
Data management and biostatistics departments of our company
Published on Tuesday April 30, 2013
Smooth Drug Development expanded data management and biomedical statistics departments.
Smooth Drug Development starts development of a new vaccine
Published on Monday April 29, 2013
Smooth Drug Development starts registration and clinical development of a new protein vaccine against pneumonia.
Purchases equipment for a Family Clinic in St-Petersburg
Published on Friday April 26, 2013
Smooth Drug Development purchases equipment for a Family Clinic in St-Petersburg.
New Smooth Drug Development office
Published on Tuesday April 23, 2013
Smooth Drug Development opens its new office on the crossing of Neva River and Obvodny Channel.